Loading
The French Sarcoma Group is the national cooperative group for soft tissue and bone sarcoma trials in France; in OnCo it is the sponsor of ANGIOTAX and the group behind LMS-04 and CABONE.
The French Sarcoma Group (Groupe Sarcome Français, GSF-GETO) is the French cooperative group for sarcoma trials. Its website could not be read for this record: gsf-geto.org does not resolve and gsf-geto.fr carried only a placeholder page on 25 September 2026, so no seat or founding year is given here. In OnCo it is the recorded sponsor of ANGIOTAX (phase 2, weekly paclitaxel in angiosarcoma, reported 2008, no registry id) and the group named on LMS-04 (NCT02997358, phase 3, doxorubicin with trabectedin in leiomyosarcoma; the registry lead sponsor is Gustave Roussy) and CABONE (NCT02243605, phase 2, cabozantinib in osteosarcoma and Ewing sarcoma, run from the Centre Léon Bérard). ClinicalTrials.gov also lists it as a collaborator on the Italian Sarcoma Group's ISG-STS 1001. It has no products of its own.
Shares Ewing sarcoma, Osteosarcoma, Sarcomas (soft tissue, bone, GIST) and the tag cooperative-group.
Shares Soft tissue sarcoma of the extremity (localised and advanced), Sarcomas (soft tissue, bone, GIST) and the tag cooperative-group.
Shares Sarcomas (soft tissue, bone, GIST) and the tag cooperative-group.
Shares Sarcomas (soft tissue, bone, GIST) and the tag cooperative-group.
Shares Retroperitoneal sarcoma, Leiomyosarcoma, Soft tissue sarcoma of the extremity (localised and advanced), Gustave Roussy.
Shares LMS-04, Retroperitoneal sarcoma, Leiomyosarcoma, Soft tissue sarcoma of the extremity (localised and advanced).
Shares LMS-04, Retroperitoneal sarcoma, Leiomyosarcoma, Soft tissue sarcoma of the extremity (localised and advanced).
Shares Osteosarcoma and the tag cooperative-group.